Mario A. Meallet

Mario Meallet practices at A Center for Visioncare Surgical & Medical Group in North Hollywood, California.

Mario Meallet's NPI, 1851510424, was assigned on April 24, 2007. Mario Meallet graduated from Harvard Medical School in 1997. Mario Meallet holds California license A67512.

Mario Meallet's primary practice is A Center for Visioncare Surgical & Medical Group, at 4418 N Vineland Ave, North Hollywood, CA 91602 in Los Angeles County. The practice phone is (818) 762-0647.

Mario Meallet's primary practice is A Center for Visioncare Surgical & Medical Group in North Hollywood, California. Mario Meallet is also affiliated with Providence Saint Joseph Medical Center. Dmand AI also links Mario Meallet to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mario Meallet practices, 3 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Mario Meallet's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Mario Meallet is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Mario Meallet's licenses on file in 2 states: California and Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation and glaucoma among the conditions Mario Meallet treats.

CMS data shows 2,791 Medicare services from Mario Meallet across 20 procedure codes in 2024, for 838 Medicare patients. Medicare paid $200,511 for them.

CMS counts 838 Medicare patients who saw Mario Meallet in 2024. The largest group is 65 to 74, with 350 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 36% are also on Medicaid. Their average risk score is 1.26, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mario Meallet's median patient age at 63, with 53% women.

In 2024, Mario Meallet wrote 3,045 Medicare Part D claims for 549 patients. 44% of them were for generic drugs. CMS names the drug for 2,941 of them, across 40 drugs with 11 or more claims each, at $405,465 in total drug cost. In 2023, CMS named 2,655 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Mario Meallet for performance year 2024, reported as part of a group. Mario Meallet accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 119 procedures of cataract surgery by Mario Meallet, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Mario Meallet in 2018. Mario Meallet's most frequent co-authors are Jennifer R. Chao, MD, PhD, Lilangi Ediriwickrema, MD and Dean Eliott, MD.

CMS Open Payments shows 354 general payments to Mario Meallet from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Valeant Pharmaceuticals International paid the most, $1,789.

Dmand AI lists 1 award for Mario Meallet.

Mario Meallet graduated from Harvard Medical School in 1997. Mario Meallet is a member of AAO.

Mario Meallet is in network with 16 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.